Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Body

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Seminars in Oncology|October 19, 2004
Ibandronate in metastatic bone painAxel Heidenreich, Carsten Ohlmann, Jean-Jacques Body
The Oncologist|November 3, 2005
Preclinical perspectives on bisphosphonate renal safetyJean-Jacques Body, Thomas Pfister, Frieder Bauss
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2017
Hypercalcaemia and hypocalcaemia: finding the balanceJean-Jacques Body, Daniela Niepel, Giuseppe Tonini
Seminars in Oncology|October 19, 2004
Profiling the safety and tolerability of bisphosphonatesJean-Jacques Body, Ingo Diel, Richard Bell
Nature Reviews. Urology|June 30, 2015
Targeting bone metastases in prostate cancer: improving clinical outcomeJean-Jacques Body, Sandra Casimiro, Luís Costa
Clinical Therapeutics|April 13, 2005
Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trialsDebu Tripathy, Jean-Jacques Body, Bengt Bergström
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot studyIsabelle Mancini, Jean-Claude Dumon, Jean-Jacques Body
Seminars in Oncology|October 19, 2004
Ibandronate reduces skeletal morbidity in patients with breast cancerDebu Tripathy A, Ingo Diel, Jean-Jacques Body
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2004
Successful use of ketamine for intractable cancer painDominique A Lossignol, Myriam Obiols-Portis, Jean-Jacques Body
European Journal of Endocrinology|September 25, 2009
Fibroblast growth factor 23 and its role in phosphate homeostasisIsolde Ramon, Pierre Kleynen, Jean-Jacques Body, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Seminars in Oncology|October 19, 2004
Ibandronate in metastatic bone painAxel Heidenreich, Carsten Ohlmann, Jean-Jacques Body
The Oncologist|November 3, 2005
Preclinical perspectives on bisphosphonate renal safetyJean-Jacques Body, Thomas Pfister, Frieder Bauss
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2017
Hypercalcaemia and hypocalcaemia: finding the balanceJean-Jacques Body, Daniela Niepel, Giuseppe Tonini
Seminars in Oncology|October 19, 2004
Profiling the safety and tolerability of bisphosphonatesJean-Jacques Body, Ingo Diel, Richard Bell
Nature Reviews. Urology|June 30, 2015
Targeting bone metastases in prostate cancer: improving clinical outcomeJean-Jacques Body, Sandra Casimiro, Luís Costa
Clinical Therapeutics|April 13, 2005
Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trialsDebu Tripathy, Jean-Jacques Body, Bengt Bergström
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot studyIsabelle Mancini, Jean-Claude Dumon, Jean-Jacques Body
Seminars in Oncology|October 19, 2004
Ibandronate reduces skeletal morbidity in patients with breast cancerDebu Tripathy A, Ingo Diel, Jean-Jacques Body
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2004
Successful use of ketamine for intractable cancer painDominique A Lossignol, Myriam Obiols-Portis, Jean-Jacques Body
European Journal of Endocrinology|September 25, 2009
Fibroblast growth factor 23 and its role in phosphate homeostasisIsolde Ramon, Pierre Kleynen, Jean-Jacques Body, et al.
Pageof 14